Abstract
INTRODUCTION: Sellar and suprasellar tumors represent 15% of intracranial tumors. The management of these conditions has recently expanded in Bouaké, following the acquisition of state-of-the-art neurosurgical equipment. OBJECTIVE: To evaluate the clinical and therapeutic profile of sellar and suprasellar tumors at the Bouaké Regional Hospital. PATIENTS AND METHODS: This was a prospective, descriptive, single-center study conducted in the Neurosurgery Department of the Bouaké Regional Hospital Center from November 2024 to March 2025. All patients admitted for sellar and suprasellar tumors were included in our study. Surgical excision was performed under neuronavigation guidance and an optical microscope. RESULTS: Analysis of a series of six patients, equally distributed by sex with a mean age of 41.3 ± 16.8 years. The mean hospital stay was 8.5 ± 6.28 days. All patients presented with intracranial hypertension syndrome and visual disturbances, while half presented with endocrine disorders. Brain MRI was systematic. The surgical approach favored the transsphenoidal endoscopic route (83.3%). Tumor excision was described as total in one-third of cases (33.3%), subtotal in half (50%), and incomplete in the remainder (16.7%). Histological examination identified meningiomas in 50% of the samples, pituitary adenomas in 33.3%, and a craniopharyngioma in 16.7%. A transient postoperative complication, diabetes insipidus, was noted in 33.3% of patients. The post-treatment outcome was considered favorable in the majority of cases (83.3%). There were no deaths. CONCLUSION: Sellar and suprasellar tumors are characterized by marked histological heterogeneity. Their management has significantly improved in Bouaké thanks to the acquisition of state-of-the-art neurosurgical equipment.